These stocks offer compelling value for businesses that continue to show solid brand strength.The tech-driven bull market has overshadowed hidden gems in other sectors, most notably consumer discretionary companies. Investors who are looking for value can find compelling opportunities among top retail brands.Here are two retail stocks with solid growth prospects that are trading well off their highs. 1. Lululemon AthleticaShares of Lululemon Athletica (LULU +0.43%) have fallen sharply this year over a weake ...

Group 1: Apple Inc. - Apple has incurred significant tariff costs, paying $800 million in tariffs during the June quarter and expecting $1.1 billion in the September quarter, which, while a small proportion of total profit, is still notable [1][9] - CEO Tim Cook has pledged to invest $600 billion in the U.S. over the next five years, which may help Apple mitigate some tariff impacts [3][9] - The company is facing uncertainty regarding future tariffs, especially with ongoing trade negotiations with China and potential 100% tariffs on foreign-made semiconductors [8][10] Group 2: RH (Restoration Hardware) - RH's stock has declined over 50% in 2025, impacted by new furniture-specific tariffs announced by President Trump, which include a 30% duty on upholstered furniture and a 50% tariff on kitchen cabinets [12][14] - The company plans to produce 52% of its upholstered furniture in the U.S. by the end of the fiscal year, which may help mitigate some tariff impacts [16] - Despite the luxury brand's pricing power, the slow housing market poses challenges for passing on costs to consumers, leading to uncertainty about the overall tariff impact on RH [18][19]

Core Viewpoint - The high-end furniture chain RH is expected to eventually make a turnaround despite recent challenges and a significant decline in stock value [1][3]. Group 1: Recent Performance and Challenges - RH's stock has decreased by 76% from its peak in 2021 and is down approximately 57% year to date due to a weak housing market, inflation, and new tariffs [2][3]. - The company reported an 8.4% increase in revenue to $899.2 million in its fiscal second quarter, with demand rising by 13.7% [5]. - Adjusted operating margin and adjusted EBITDA improved by 340 basis points to 15.1% and 20.6%, respectively, indicating strong profitability despite macroeconomic headwinds [5][6]. Group 2: Strategic Adjustments - CEO Gary Friedman has proactively responded to tariffs, with a projection that 52% of upholstered furniture will be sourced from the U.S. by year-end [7]. - RH has significantly reduced its reliance on China, with sourcing expected to drop from 16% in Q1 to just 2% in Q4, while also addressing production in India facing high tariffs [8][9]. Group 3: Historical Context and Future Growth - RH's stock previously collapsed in 2016 after shifting to a membership model, but rebounded to an all-time high by 2017, suggesting potential for recovery despite current challenges [10][11]. - The company is expanding in Europe, with gallery demand in RH England up 76% in the second quarter, and new stores in major markets like Paris showing strong performance [12]. - RH is diversifying its business by opening restaurants, guesthouses, and engaging in turnkey home sales through RH Residences, positioning itself for future growth [13].

Core Viewpoint - Roche's drug, Ocrelizumab (brand name: Gazyva/Gazyvaro), has received FDA approval for a new indication to treat adult patients with active lupus nephritis (LN) who are undergoing standard treatment [1] Group 1: Drug Approval and Indication - Ocrelizumab is the first CD20-targeted therapy approved by the FDA for the treatment of lupus nephritis [1] - The approval is based on positive results from the Phase II NOBILITY study and the Phase III REGENCY study [1] Group 2: Clinical Study Results - In the REGENCY study, 46.4% of patients receiving Ocrelizumab combined with standard treatment achieved complete renal response (CRR) at week 76, compared to 33.1% in the standard treatment group (adjusted difference of 13.4%, 95% CI: 2.0%-24.8%; P=0.0232) [1] - The Ocrelizumab group also showed clinically meaningful improvements in complement levels, as well as reductions in anti-dsDNA antibodies, disease activity, and inflammatory markers compared to the standard treatment group [1]

Core Insights - The article emphasizes the importance of understanding that past performance does not guarantee future results, highlighting the need for careful analysis before making investment decisions [2][3] Company and Industry Summary - The article does not provide specific information regarding any companies or industries, focusing instead on general investment principles and disclaimers [1][2][3]

Group 1 - Gary Alexander has extensive experience in covering technology companies on Wall Street and working in Silicon Valley, which provides insights into current industry trends [1] - He has been a contributor to Seeking Alpha since 2017 and has been quoted in various web publications, indicating his influence in the investment community [1] - His articles are syndicated to popular trading apps like Robinhood, suggesting a broad reach and impact on retail investors [1]

Group 1 - RH announced the opening of RH Manhasset, an immersive retail experience covering 19,000 square feet across three levels [1] - The new location integrates luxury home furnishings with rare art, antiques, and artifacts from around the world [1] Group 2 - RH is a curator of design, taste, and style in the luxury lifestyle market [2] - The company offers collections through retail galleries, sourcebooks, and various online platforms [2]

Core Viewpoint - The Trump Administration's new tariffs on furniture imports are set to take effect on October 14, impacting various companies differently, with some facing significant margin pressure while others may benefit from the changes [1][3][5]. Impact on Companies - RH Inc. is heavily reliant on imports from Vietnam and China, with over 70% of its products sourced from these countries, making it vulnerable to the new tariffs, which include a 25% tariff on upholstered furniture and kitchen cabinets, rising to 30% and 50% respectively by 2026 [6][8]. - RH has warned of a potential revenue hit of $30 million in the second half of the year due to tariff pressures, with an additional $40 million impact expected in 2026 [7]. - Wayfair, while somewhat insulated due to its marketplace model, will still face challenges as 35-40% of its third-party suppliers are located in Asian countries affected by the tariffs, forcing the company to make difficult decisions regarding cost absorption or price increases [10][11][12]. - Ethan Allen Interiors stands to benefit from the tariffs due to its strong domestic manufacturing presence, with approximately 75% of its merchandise produced in North America, allowing it to maintain prices or implement small price hikes without sacrificing volume [14][15]. Market Reactions - RH's stock has declined by 10% this month, reflecting investor concerns over its vulnerability to tariff impacts and a downgraded rating from Zacks Research to Strong Sell [9]. - Wayfair's stock has increased over 100% year-to-date, but the new tariffs may present an opportunity for profit-taking [13]. - Ethan Allen's stock has seen limited growth of 5% year-to-date, but the tariffs could attract new customers and revive sales growth, which has been down 4.9% year-over-year [15].

Core Insights - Recurve Capital reported a strong performance in Q2 2025, achieving a gross return of +31%, significantly outperforming the S&P 500 and Nasdaq, which returned +10.6% and +17.8% respectively [1] - Year-to-date, the fund has returned +14.8% gross and +12% net [1] Company Highlights - Recurve Capital highlighted RH (NYSE:RH) as a notable stock, which experienced a one-month return of 13.37% but has lost 39.00% of its value over the past 52 weeks [2] - As of October 2, 2025, RH's stock closed at $203.79 per share, with a market capitalization of $3.82 billion [2] - Despite the negative contributions from RH and another company, Recurve Capital remains optimistic about their future performance, expecting them to become meaningful positive contributors [2] Hedge Fund Activity - RH (NYSE:RH) was held by 49 hedge fund portfolios at the end of Q2 2025, an increase from 46 in the previous quarter [3] - While acknowledging RH's potential, the analysis suggests that certain AI stocks may offer greater upside potential with less downside risk [3]

Market Reactions to Tariff Announcements - President Trump announced a 100% tariff on all movies made outside the United States, aiming to rejuvenate the American film industry, which led to a decline in shares for Netflix and Warner Bros Discovery [2][3] - The immediate market reaction included Netflix shares dropping 1.4% and Warner Bros Discovery falling 0.6% on September 29, with previous tariff threats causing even larger declines [3] - Other sectors affected included home furnishings, with Williams-Sonoma and RH experiencing significant drops in share prices due to new tariffs on furniture and lumber [4] Impact on the Pharmaceutical Industry - The pharmaceutical sector faced a potential 100% tariff on branded drugs unless companies agreed to build manufacturing plants in the U.S. or reduce prices [6] - Pfizer secured a three-year reprieve from tariffs by committing to cut U.S. drug prices by up to 85%, resulting in a 6.8% surge in its stock price [7] - Other pharmaceutical companies, including Roche and Novartis, also saw stock gains following the Pfizer deal, indicating a positive market response to tariff negotiations [8][9] Agricultural Sector Developments - President Trump announced a meeting with Chinese President Xi Jinping to discuss agriculture, which is expected to be a major topic, particularly regarding soybean purchases [10] - Following hints of positive trade developments, soybean prices rebounded, with November soybeans rising 1.3% to $10.15 1/4 a bushel on October 1 [11] - The volatility in soybean prices reflects the market's sensitivity to trade news, with previous declines occurring after a lack of concrete outcomes from Trump-Xi communications [11] Regulatory Changes in Banking - The Trump administration is proposing significant changes to U.S. capital rules, aiming to reduce regulatory burdens on banks, which could lead to a decrease in capital requirements [12][13] - While large banks like JPMorgan Chase and Bank of America may face challenges from lower interest margins, the overall sentiment in the banking sector remains optimistic about potential deregulation [13] - Critics warn that these changes could leave the financial system vulnerable, estimating a potential $200 billion reduction in banking system capital [13] Overall Market Trends - Major indices, including the Dow Jones and S&P 500, have generally continued to rise despite the volatility caused by tariff announcements and trade negotiations [15] - The market is experiencing a "stagflation-lite" scenario, with predictions of higher inflation and unemployment linked to the ongoing tariff impacts [15] - Investors are left questioning the sustainability of market gains amid the unpredictable nature of presidential announcements and their effects on various sectors [16]